Cite
HARVARD Citation
Xagara, A. et al. (n.d.). 21P Peripheral pre-existing T cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients. Immuno-oncology technology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xagara, A. et al. (n.d.). 21P Peripheral pre-existing T cell immunity as predictive biomarker in cancer immunotherapy for NSCLC patients. Immuno-oncology technology. p. . [Online].